Investigational Site Number : 1240011

Calgary, Alberta T3R 1W7

1 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Multiple Sclerosis

Studies at this site

• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype — Recruiting now
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling